Elastic band resistance training for heart failure patients with muscle loss
The Effectiveness of an Elastic Band -Based Progressive Resistance Training (EB-PRT) in Improving Sarcopenia and Clinical Outcomes Among Patients With Heart Failure: A Pilot Mixed-method Study
NA · The University of Hong Kong · NCT06161402
This study tests if using elastic bands for strength training can help heart failure patients who have lost muscle gain it back and feel better.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 62 (estimated) |
| Ages | 50 Years and up |
| Sex | All |
| Sponsor | The University of Hong Kong (other) |
| Locations | 1 site (Hong Kong) |
| Trial ID | NCT06161402 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of elastic band-progressive resistance training (EB-PRT) on improving sarcopenia in patients with heart failure. It involves a 14-week intervention where participants will engage in resistance training designed to increase skeletal muscle mass, followed by qualitative interviews to assess their experiences. The study aims to provide evidence-based practices to enhance the prognosis of heart failure patients suffering from sarcopenia. A total of 62 participants will be enrolled, and the study will last for 40 weeks, including two post-test evaluations.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 50 and older with a confirmed diagnosis of heart failure and evidence of sarcopenia.
Not a fit: Patients with acute respiratory or musculoskeletal conditions that prevent them from exercising may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve muscle strength and overall health outcomes for heart failure patients.
How similar studies have performed: Other studies have shown promising results with resistance training in similar populations, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. age ≥ 50; 2. has a confirmed clinical diagnosis of HF in the electronic health record for at least 6 months to ensure adequate disease exposure; 3. meeting the Asian Working Group of Sarcopenia's criteria2 \[grip strength measured by dynamometer (Male: \<28kg; Female: \<18kg); low physical function (defined by Short Physical Performance Battery score ≤9) and reduced muscle mass by bioimpedance analysis (Inbody Technology 270; Male: appendicular skeletal muscular index (ASMI) \<7.0kg/m2, Female: \<5.7kg/m2)\]; 4. has stable HF and do not have any acute respiratory and musculo-skeletal condition which contradict them from practising exercise; 5. no regular resistance training for the previous 6 months. Exclusion Criteria: \-
Where this trial is running
Hong Kong
- The University of Hong Kong — Hong Kong, Hong Kong (RECRUITING)
Study contacts
- Principal investigator: Doris Sau Fung YU, PhD — The University of Hong Kong
- Study coordinator: Doris Sau Fung YU, PhD
- Email: dyu1@hku.hk
- Phone: 852 3817 6319
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Heart Failure, Sarcopenia, Resistant Training